. Author manuscript; available in PMC: 2016 Jul 4.

Published in final edited form as: Kidney Int. 2016 Jan 4;89(1):95–104. doi: 10.1038/ki.2015.315

Table 2.

MicroCT

Proximal Tibia	Normal (n=8)	CKD (Vehicle) (n=9)	CKD (Raloxifene) (n=10)
BV/TV (%)^§	17.04 ± 3.34	11.26 ± 1.51 ^*	14.9 ± 2.70 ^#
Tb.Th (mm)^¶	0.106 ± 0.010	0.108 ± 0.004	0.103 ± 0.007
Tb.N (1/mm)^§	1.611 ± 0.253	1.052 ± 0.150 ^*	1.451 ± 0.211 ^#
Tb.Sp (mm)^§	0.369 ± 0.044	0.604 ± 0.114 ^*	0.420 ± 0.055 ^#
Femoral Diaphysis	Normal (n=8)	CKD (Vehicle) (n=9)	CKD (Raloxifene) (n=10)
Ct.Th (mm)^§	0.876 ± 0.037	0.748 ± 0.056 ^*	0.783 ± 0.039 ^*
Ct.Ar (mm²)^¶	8.767 ± 0.631	7.324 ± 0.358 ^*	7.611 ± 0.397 ^*
I_ap (mm⁴)^¶	15.00 ± 2.59	12.40 ± 0.58 ^*	12.30 ± 1.35 ^*
I_ml (mm⁴)^¶	10.23 ± 1.56	7.50 ± 0.59 ^*	7.86 ± 0.73 ^*
Ct.Po (%)^¶	0.690 ± 0.324	0.948 ± 0.401	0.467 ± 0.274 ^#
Lumbar Vertebra	Normal (n=8)	CKD (Vehicle) (n=9)	CKD (Raloxifene) (n=10)
BV/TV (%)^§	41.88 ± 2.92	30.01 ± 3.98 ^*	36.27 ± 1.76 ^*^#
Tb.Th (mm)^¶	0.119 ± 0.004	0.110 ± 0.007 ^*	0.108 ± 0.005 ^*
Tb.N (1/mm)^§	3.581 ± 0.258	2.726 ± 0.324 ^*	3.401 ± 0.129 ^#
Tb.Sp (mm)^§	0.213 ± 0.021	0.280 ± 0.031 ^*	0.235 ± 0.014 ^* ^#
Ct.Th (mm)^¶	0.236 ± 0.033	0.170 ± 0.012 ^*	0.184 ± 0.025 ^*

^§

One-Way ANOVA followed by Fisher’s LSD tests

^¶

Kruskal-Wallis test followed Mann-Whitney U tests (with Bonferroni correction)

vs. Normal

vs. CKD (Vehicle)